2005
12.19.2005 MonoSol Rx announces the hiring of Alexander Mark Schobel as its new president and CEO, and the relocation of the company's headquarters to New Jersey
10.25.2005 MonoSol Rx today announced that it has received a successful audit report for the manufacture of pharmaceuticals under the Australian Code of GMP of Medicinal Products
08.24.2005 MonoSol Rx, LLC announced today that it has initiated the DEA Registration of its Tennessee development facility and its Indiana manufacturing facility for Class II-V scheduled drugs
The information contained in these releases was current on the date the releases were issued and will become outdated over time. MonoSol Rx does not assume any responsibility for updating information in these releases.
